The Cloud Computing in Cell Biology, Genomics and Drug Development Market was valued at USD 7.2 Billion in 2025, and is projected to reach USD 15.6 Billion by 2030, rising at a CAGR of 16.7%.
The global market for cloud computing in cell biology, genomics and drug development has experienced rapid expansion, driven by the growing need for scalable, secure and AI-enabled platforms to manage the vast datasets generated in modern life sciences research. Rising adoption of precision medicine and multiomics approaches is a key driver, as researchers, clinicians and pharmaceutical companies increasingly rely on cloud-based infrastructure to analyze genomic, transcriptomic, proteomic and clinical datasets. Advances in high-performance computing (HPC), federated learning and AI-driven bioinformatics pipelines are transforming discovery workflows, accelerating clinical trial design, and enabling real-time integration of real-world evidence (RWE).
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
The global market for cloud computing in cell biology, genomics and drug development has experienced rapid expansion, driven by the growing need for scalable, secure and AI-enabled platforms to manage the vast datasets generated in modern life sciences research. Rising adoption of precision medicine and multiomics approaches is a key driver, as researchers, clinicians and pharmaceutical companies increasingly rely on cloud-based infrastructure to analyze genomic, transcriptomic, proteomic and clinical datasets. Advances in high-performance computing (HPC), federated learning and AI-driven bioinformatics pipelines are transforming discovery workflows, accelerating clinical trial design, and enabling real-time integration of real-world evidence (RWE).
Report Scope
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
The report includes:
- 52 data tables and 51 additional tables
- An analysis of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the market size and revenue growth prospects, along with a market share analysis by the branch of biology, deployment type, application, end user and region
- Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Information about key partnerships between cloud service providers and pharma/biotech companies and investment in the pharmaceutical R&D sector
- A relevant patent analysis, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading companies, including Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
Chapter 6 Market Segmentation Analysis
Chapter 7 Patent Review/New Developments
Chapter 8 Competitive Landscape
Chapter 9 Appendix
List of Tables
List of Figures
Companies Mentioned
- Alphabet Inc. (Google Inc.)
- Amazon Web Services Inc.
- Arisglobal
- Benchling
- Box
- Cisco Systems Inc.
- Cognizant
- Dnanexus Inc.
- IBM Corp.
- Informatica Inc.
- Microsoft
- Oracle
- Rescale Inc.
- Salesforce Inc.
- SAP SE
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | February 2026 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 7.2 Billion |
| Forecasted Market Value ( USD | $ 15.6 Billion |
| Compound Annual Growth Rate | 16.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
